Gd-DTPA in the evaluation of the normal and adnormal cavernous sinus
Creators
Description
This paper reports on Gd-DTPA used in the evaluation of normal and abnormal cavernous sinus anatomy. Twenty-five normal subjects and 11 patients with cavernous sinus invasion were studied before Gd-DTPA enhancement. Normal studies were assessed for the conspicuity of the dural margins, the trigeminal cistern, and intracavernous and exiting cranial nerves. Contrast medium enhancement improved deductibility of the medical cavernous sinus margin (68% vs 38% on precontrast images) and intracavernous cranial nerves. Cranial nerves were inconsistently seen even on postcontrast images (cranial nerve III, 88%; v1, 36%, V2, 38%). On the abnormal images, contrast enhancement was beneficial in defining the relationship of tumor to parasellar structures, egress of tumor through bony foramina, and compression of the trigeminal cistern
Additional details
Publishing Information
- Publisher
- Radiological Society of North America Inc.
- Imprint Place
- Oak Brook, IL (USA)
- Imprint Title
- Proceedings of the 75th anniversary scientific assembly and annual meeting of the Radiological Society of North America (Abstracts)
- Imprint Pagination
- 654 p.
- Journal Page Range
- p. 286.
Conference
- Title
- 75. anniversary scientific assembly and annual meeting of the Radiological Society of North America.
- Dates
- 26 Nov - 1 Dec 1989.
- Place
- Chicago, IL (USA).
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 21079266
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- BRAIN; COMPRESSION; DIAGNOSIS; DTPA; GADOLINIUM; IMAGE PROCESSING; NEOPLASMS; NERVE TISSUE; NMR IMAGING; VEINS
- Descriptors DEC
- AMINO ACIDS; BLOOD VESSELS; BODY; CARBOXYLIC ACIDS; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CHELATING AGENTS; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; ELEMENTS; METALS; NERVOUS SYSTEM; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANS; RADIOPROTECTIVE SUBSTANCES; RARE EARTHS; RESPONSE MODIFYING FACTORS; TISSUES
Optional Information
- Secondary number(s)
- CONF-8911163--.